Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oligobs Difficult Periods (also known as Oligobs Règles Difficiles) is an approved food supplement developed by Laboratoire CCD for the management of menstrual discomfort in women and adolescents aged 12 and older. It is formulated to help reduce abdominal pain and cramps, alleviate fatigue, and promote physical and mental well-being during menstruation. The product is a multi-ingredient formulation containing chamomile matricaria extract, ginger extract, fennel extract, magnesium (as bisglycinate and marine magnesium oxide), zinc sulfate, and vitamin B6 (pyridoxine hydrochloride). As a dietary supplement, it does not target a single biological pathway but acts through the synergistic nutritional and botanical properties of its active components.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Oligobs Difficult Periods.